Gastric xanthelasma and metabolic disorders: A large retrospective study among Chinese population

Table 2 Metabolic factors in xanthelasma and non-xanthelasma groups

Variables	Non-xanthelasma	Xanthelasma	P
n (male/female)	99 (41/58)	99 (41/58)	1.000
Age (yr)	55 ± 13	56 ± 11	0.537
Body mass index (kg/m2)	22.1 ± 2.3	23.2 ± 2.3	0.288
Systolic blood pressure	119 ± 16	117 ± 13	0.818
Diastolic blood pressure	73 ± 10	73 ± 13	0.785
Alanine aminotransferase	20 ± 13	20 ± 9	0.953
Aspartate aminotransferase (U/L)	21 ± 6	21 ± 4	0.669
Alkaline phosphatase (U/L)	67 ± 18	72 ± 21	0.202
γ-Glutamyltransferase (U/L)	23 ± 18	27 ± 32	0.327
Total bilirubin (μmol/L)	12.2 ± 3.8	13.4 ± 8.5	0.246
Triglyceride (mmol/L)	1.07 ± 0.55	1.33 ± 0.63	< 0.05
Albumin (g/L)	47.5 ± 3.2	46.2 ± 3.8	0.063
Total cholesterol (mmol/L)	4.51 ± 0.77	4.59 ± 0.78	0.614
HDL-cholesterol (mmol/L)	1.45 ± 0.35	1.26 ± 0.33	< 0.01
LDL cholesterol (mmol/L)	2.42 ± 0.61	2.56 ± 0.52	0.259
Fasting plasma glucose (mmol/L)	4.71 ± 0.50	5.08 ± 0.58	< 0.001
Hb1Ac (%)	5.49 ± 1.19	5.5 ± 0.17	0.984
Serum uric acid (μmol/L)	303 ± 79	328 ± 91	0.119
CEA (ng/mL)	1.8 ± 1.2	2.8 ± 1.6	< 0.001
CA199 (U/mL)	8.3 ± 9.5	9.4 ± 12	0.780

HDL-cholesterol: High density lipoprotein cholesterol; LDL-cholesterol: Low density lipoprotein cholesterol; CA199: Carbohydrate antigen 199; CEA: Carcinoembryonic antigen.